News from cumberland pharmaceuticals inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 07, 2015, 16:05 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals Reports First Quarter 2015 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...

Apr 30, 2015, 16:05 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2015 financial results after the market...

Mar 03, 2015, 17:30 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...

Mar 03, 2015, 16:05 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...

Feb 24, 2015, 08:00 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2014 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release fourth quarter and annual 2014 financial results after the...

Feb 11, 2015, 08:05 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals Announces Pipeline Expansion With Boxaban™ (ifetroban) Oral Capsule

 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced an expansion of its pipeline with a new Phase II development program. The...

Feb 02, 2015, 08:30 ET
Cumberland Pharmaceuticals Logo

Phase IV Studies Published Supporting The Safety Of A Shortened Infusion Time Of Caldolor® (ibuprofen) Injection

 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of two Phase IV studies adding to the growing body of...

Nov 04, 2014, 16:05 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...

Oct 21, 2014, 16:05 ET
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 4, 2014

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release third quarter 2014 financial results after the market closes on...

Oct 14, 2014, 16:05 ET
Cumberland Pharmaceuticals Logo

Caldolor® Safely Treats Fever In Hospitalized Children

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that treatment with intravenous ibuprofen was superior in reducing temperatures in...

Oct 10, 2014, 15:11 ET
Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)

Caldolor® Provides Favorable Inflammatory Response Results In Laparoscopic Cholecystectomy Surgery Patients

 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that preoperative intravenous ibuprofen improved overall quality of recovery in...

Aug 05, 2014, 16:05 ET
Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)

Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...

Jul 22, 2014, 16:05 ET
Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)

Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release second quarter 2014 financial results after the market closes on...

May 13, 2014, 16:05 ET
Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)

Cumberland Pharmaceuticals Reports First Quarter 2014 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...

May 07, 2014, 07:00 ET
Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)

Cumberland Pharmaceuticals Launches Vaprisol® Promotion

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the launch of its active promotional campaign to support its new Vaprisol®...

May 06, 2014, 07:00 ET
Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)

Cumberland Pharmaceuticals And Gloria Pharmaceuticals Announce Joint Research & Development Investment

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) and China's Gloria Pharmaceuticals Co. (SHE: 002437) announced today a joint research &...

Apr 29, 2014, 17:00 ET

Cumberland Pharmaceuticals To Announce First Quarter 2014 Financial Results On May 13, 2014

NASHVILLE, Tenn., April 29, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first...

Mar 07, 2014, 14:04 ET

Caldolor® Pediatric Pain Study Results To Be Presented At The Pediatric Anesthesiology 2014 Conference

 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of...

Mar 04, 2014, 16:05 ET

Cumberland Pharmaceuticals Reports 2013 Fourth Quarter And Annual Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...

Mar 03, 2014, 08:05 ET

Cumberland Pharmaceuticals Acquires Vaprisol® from Astellas Pharma US, Inc.

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol® from Astellas Pharma US, Inc. Vaprisol®...